These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30187134)

  • 1. Biomarkers in Islet Cell Transplantation for Type 1 Diabetes.
    AlRashidi FT; Gillespie KM
    Curr Diab Rep; 2018 Sep; 18(10):94. PubMed ID: 30187134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta Cell Death by Cell-free DNA and Outcome After Clinical Islet Transplantation.
    Gala-Lopez BL; Neiman D; Kin T; O'Gorman D; Pepper AR; Malcolm AJ; Pianzin S; Senior PA; Campbell P; Glaser B; Dor Y; Shemer R; Shapiro AMJ
    Transplantation; 2018 Jun; 102(6):978-985. PubMed ID: 29329189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MicroRNA Landscape of Acute Beta Cell Destruction in Type 1 Diabetic Recipients of Intraportal Islet Grafts.
    Martens GA; Stangé G; Piemonti L; Anckaert J; Ling Z; Pipeleers DG; Gorus FK; Mestdagh P; De Smet D; Vandesompele J; Keymeulen B; Roels S
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of beta cell replacement outcomes.
    Chang CA; Haque WZ; Yoshimatsu G; Balajii PS; Lawrence MC; Naziruddin B
    Panminerva Med; 2016 Mar; 58(1):59-71. PubMed ID: 26763742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unmethylated Insulin DNA Is Elevated After Total Pancreatectomy With Islet Autotransplantation: Assessment of a Novel Beta Cell Marker.
    Bellin MD; Clark P; Usmani-Brown S; Dunn TB; Beilman GJ; Chinnakotla S; Pruett TL; Ptacek P; Hering BJ; Wang Z; Gilmore T; Wilhelm JJ; Hodges JS; Moran A; Herold KC
    Am J Transplant; 2017 Apr; 17(4):1112-1118. PubMed ID: 27643615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing the loss of beta-cell mass in islet transplantation.
    Emamaullee JA; Shapiro AM
    Cell Transplant; 2007; 16(1):1-8. PubMed ID: 17436849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Exosomes in Islet Transplantation.
    Mattke J; Vasu S; Darden CM; Kumano K; Lawrence MC; Naziruddin B
    Front Endocrinol (Lausanne); 2021; 12():681600. PubMed ID: 34447351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in islet immunobiology and transplantation.
    Pileggi A; Klein D; Fotino C; Bravo-Egaña V; Rosero S; Doni M; Podetta M; Ricordi C; Molano RD; Pastori RL
    Immunol Res; 2013 Dec; 57(1-3):185-96. PubMed ID: 24242759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Cytokines as Biomarkers in Islet Cell Transplantation for Type 1 Diabetes.
    van der Torren CR; Verrijn Stuart AA; Lee D; Meerding J; van de Velde U; Pipeleers D; Gillard P; Keymeulen B; de Jager W; Roep BO
    PLoS One; 2016; 11(1):e0146649. PubMed ID: 26751709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLC30A8 polymorphism and BMI complement HLA-A*24 as risk factors for poor graft function in islet allograft recipients.
    Balke EM; Demeester S; Lee D; Gillard P; Hilbrands R; Van de Velde U; Van der Auwera BJ; Ling Z; Roep BO; Pipeleers DG; Keymeulen B; Gorus FK
    Diabetologia; 2018 Jul; 61(7):1623-1632. PubMed ID: 29679103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Horizons in the Treatment of Type 1 Diabetes: More Intense Immunosuppression and Beta Cell Replacement.
    Couri CEB; Malmegrim KCR; Oliveira MC
    Front Immunol; 2018; 9():1086. PubMed ID: 29868031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of β-cells for autologous transplantation in type 1 diabetes.
    Schuetz C; Markmann JF
    Pharmacol Res; 2015 Aug; 98():60-8. PubMed ID: 25801943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-Cell Replacement: Pancreas and Islet Cell Transplantation.
    Niclauss N; Meier R; Bédat B; Berishvili E; Berney T
    Endocr Dev; 2016; 31():146-62. PubMed ID: 26824893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of end-differentiated β-cell phenotype following pancreatic islet transplantation.
    Anderson SJ; White MG; Armour SL; Maheshwari R; Tiniakos D; Muller YD; Berishvili E; Berney T; Shaw JAM
    Am J Transplant; 2018 Mar; 18(3):750-755. PubMed ID: 28949067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Death and dysfunction of transplanted β-cells: lessons learned from type 2 diabetes?
    Potter KJ; Westwell-Roper CY; Klimek-Abercrombie AM; Warnock GL; Verchere CB
    Diabetes; 2014 Jan; 63(1):12-9. PubMed ID: 24357689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet alpha cell number is maintained in microencapsulated islet transplantation.
    Bohman S; King AJF
    Biochem Biophys Res Commun; 2008 Dec; 377(2):729-733. PubMed ID: 18950602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in Encapsulation and Delivery Strategies for Islet Transplantation.
    Wu S; Wang L; Fang Y; Huang H; You X; Wu J
    Adv Healthc Mater; 2021 Oct; 10(20):e2100965. PubMed ID: 34480420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygenation strategies for encapsulated islet and beta cell transplants.
    Papas KK; De Leon H; Suszynski TM; Johnson RC
    Adv Drug Deliv Rev; 2019 Jan; 139():139-156. PubMed ID: 31077781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The state of the art of islet transplantation and cell therapy in type 1 diabetes.
    Pellegrini S; Cantarelli E; Sordi V; Nano R; Piemonti L
    Acta Diabetol; 2016 Oct; 53(5):683-91. PubMed ID: 26923700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligomeric collagen as an encapsulation material for islet/β-cell replacement: effect of islet source, dose, implant site, and administration format.
    Stephens CH; Morrison RA; McLaughlin M; Orr K; Tersey SA; Scott-Moncrieff JC; Mirmira RG; Considine RV; Voytik-Harbin S
    Am J Physiol Endocrinol Metab; 2020 Aug; 319(2):E388-E400. PubMed ID: 32543944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.